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The PHF21B gene is associated with major depression and
modulates the stress response
M-L Wong1,2,10, M Arcos-Burgos3,4,10, S Liu1,2, JI Vélez3,5, C Yu1,2, BT Baune6, MC Jawahar6, V Arolt7, U Dannlowski7,8, A Chuah3,
GA Huttley3, R Fogarty1, MD Lewis1,2, SR Bornstein7,9 and J Licinio1,2
Major depressive disorder (MDD) affects around 350 million people worldwide; however, the underlying genetic basis remains
largely unknown. In this study, we took into account that MDD is a gene-environment disorder, in which stress is a critical
component, and used whole-genome screening of functional variants to investigate the ‘missing heritability’ in MDD. Genome-wide
association studies (GWAS) using single- and multi-locus linear mixed-effect models were performed in a Los Angeles Mexican-
American cohort (196 controls, 203 MDD) and in a replication European-ancestry cohort (499 controls, 473 MDD). Our analyses took
into consideration the stress levels in the control populations. The Mexican-American controls, comprised primarily of recent
immigrants, had high levels of stress due to acculturation issues and the European-ancestry controls with high stress levels were
given higher weights in our analysis. We identiﬁed 44 common and rare functional variants associated with mild to moderate MDD
in the Mexican-American cohort (genome-wide false discovery rate, FDR, o0.05), and their pathway analysis revealed that the
three top overrepresented Gene Ontology (GO) processes were innate immune response, glutamate receptor signaling and
detection of chemical stimulus in smell sensory perception. Rare variant analysis replicated the association of the PHF21B gene
in the ethnically unrelated European-ancestry cohort. The TRPM2 gene, previously implicated in mood disorders, may also be
considered replicated by our analyses. Whole-genome sequencing analyses of a subset of the cohorts revealed that European-
ancestry individuals have a signiﬁcantly reduced (50%) number of single nucleotide variants compared with Mexican-American
individuals, and for this reason the role of rare variants may vary across populations. PHF21b variants contribute signiﬁcantly to
differences in the levels of expression of this gene in several brain areas, including the hippocampus. Furthermore, using an animal
model of stress, we found that Phf21b hippocampal gene expression is signiﬁcantly decreased in animals resilient to chronic
restraint stress when compared with non-chronically stressed animals. Together, our results reveal that including stress level data
enables the identiﬁcation of novel rare functional variants associated with MDD.
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INTRODUCTION
Major depressive disorder (MDD) causes considerable morbidity
and mortality,1–5 and is a leading contributor to the global burden
of disease.6 However, we know little about its underlying
fundamental biology and the genes conferring susceptibility to
this disorder.7
Decades of investigation have revealed little of the genetic basis
of MDD. Last year, the ﬁrst two loci for MDD were identiﬁed in
Chinese women with severe symptoms, one near the SIRT1 gene
and the other in an intron of the LHPP gene. However, neither
gene has been replicated in European-ancestry populations,8 and
a mega-analysis of several genome-wide association studies
(GWAS) in MDD did not ﬁnd any single nucleotide polymorphism
(SNP) with genome-wide signiﬁcance in European-ancestry
populations.9 These results highlight the challenges facing this
ﬁeld despite the substantial inheritance of depression (37–
38%),10,11 which is even higher (~70%) when considering
diagnostic unreliability.12 There have been various explanations
postulated for this genetic conundrum, including disease hetero-
geneity and the types of genetic variation studied.13 Recently, the
risk of depressive symptoms was associated with a rare missense
variant in the LIPG gene; in addition, data from over 75 000 and
230 000 individuals with self-reported clinical diagnosis of depres-
sion and no self-reported history of depression, respectively,
identiﬁed 15 genetic loci in European-ancestry populations.14,15
In MDD, as in other mental disorders, there is a need for new
genomic approaches to identify the ‘missing heritability’, which
has arisen from applying the ‘common disease, common variant’
hypothesis. An alternative approach proposes that genetic risk can
be better ascertained by considering nonlinear interactions
between rare genetic variants that have stronger phenotypic
effects.16–20 Coding and non-coding ‘functional’ SNPs (that is,
those resulting in amino acid, splicing, regulatory or epigenetic
changes) may have a major impact on phenotype.21 Indeed,
important fractions of the current missing heritability of complex
traits could be due to genetic interactions.20 Following this lead,
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we previously analyzed a small set of nonsynonymous SNPs and
reported that their interactions with clinical and environment
variables were signiﬁcantly associated with MDD.22 Those ﬁndings
provided a rationale to focus on functional SNPs.
MDD is a gene-environment disorder;3 however, genetic studies
have not accounted for the fact that stressful events are a critical
factor when selecting a control cohort. Unique features of this
study include: (1) a cohort of cases and controls comprised of
Mexican-Americans of the greater Los Angeles area who were
mainly recent immigrants born in Mexico23 and who experienced
signiﬁcant levels of hyperactivation of the hypothalamic–pitui-
tary–adrenal axis related to challenges, distress and acculturation
issues related to immigration;24,25 (2) type of genetic variations
studied; (3) an ethnically diverse replication cohort with stress
level data in controls. We performed whole-genome screening
speciﬁcally of functional variants to investigate whether our
experimental design could contribute to explain the ‘missing
heritability’ of MDD. We obtained whole-genome sequencing for a
small subset of individuals from both cohorts, and also performed
an animal study to investigate the functional relevance of our
genetic ﬁnding.
MATERIALS AND METHODS
The Los Angeles Mexican-American cohort
We used a Los Angeles Mexican-American cohort of 399 subjects aged 19–
65 years: 203 with mild to moderate MDD cases (50.88%) and 196 controls
(49.12%). There were no differences in age between MDD cases and
controls (Supplementary Table S1). Participants gave written informed
consent, and detailed demographic, epidemiological and clinical descrip-
tions of this sample have been presented elsewhere.22,23,26 Brieﬂy, our
Mexican-American participants had at least three grandparents born in
Mexico. They participated in a pharmacogenetic study with antidepressant
drugs, and were assessed by the Structured Clinical Interview (SCID) for the
Diagnostic and Statistical Manual of Mental Disorders (DSM), using the
DSM-IV diagnosis of current, unipolar major depressive episode and a
HAM-D21 (21-Item Hamilton Depression Rating Scale) score of 18 or
greater with item number 1 (depressed mood) rated 2 or greater. This
study was approved by the Institutional Review Boards of the Universities
of California Los Angeles and Miami, USA, and by the Human Research
Ethics Committees of the Australian National University and Bellbery,
Australia, and it was registered in ClinicalTrials.gov (NCT00265291).22,23,26
Mexican-American MDD patients had comprehensive psychiatric and
medical assessments in their primary language using diagnostic and rating
instruments fully validated in English and Spanish. Exclusion criteria
included active medical illnesses that could be etiologically related to the
ongoing depressive symptoms, active suicidal intent, pregnancy/lactation,
illicit drug use and/or alcohol abuse in the last 3 months, other major
mental disorders, except for anxiety related disorders.22,23,26 Control age-
and gender-matched Mexican-American individuals were recruited from
the same Mexican-American community in Los Angeles and were in
general good health but were not screened for medical or psychiatric
illnesses.22,23,26
The European-ancestry cohort
We used a European-ancestry cohort of 972 individuals (473 (51%) cases
and 499 (49%) controls) for our replication study. The effects of age
differences between MDD cases and controls were controlled in the linear
mixed-effect models (LMEMs) maximization by introducing age as a
covariate (Supplementary Tables S1 and S2). Participants gave written
informed consent and were recruited under two protocols: (1) Mood
disorder studies Münster (comprised of the Münster neuroimaging and the
moodinﬂame studies, which have been conducted by the Department of
Psychiatry and Psychotherapy, University of Münster, Münster, Germany),
and (2) the Cognitive function and mood disorders study (conducted by
the Discipline of Psychiatry, University of Adelaide, South Australia,
Australia). The SCID/MINI was used to ascertain that healthy controls were
free from lifetime history of psychiatric disorders; for this cohort, the main
diagnostic and mood assessment instruments used were also DSM-IV
criteria for MDD and HAM-D21, respectively. Previous traumatic events
were assessed using the Childhood Trauma Questionnaire/Family
Inventory of Life Events in cases and controls. Exclusion criteria included
any neurologic abnormalities, substance-related disorders, psychotic/
mania or hypomania symptoms, treatment with benzodiazepine, previous
electroconvulsive therapy, and usual magnetic resonance imaging (MRI)-
contraindications. European-ancestry cohort samples were studied under
approved Human Research Ethics Committees protocols at the University
of Münster, Germany, and University of Adelaide and Flinders University,
South Australia, Australia.
Power analysis for the European-ancestry cohort study. Power estimation
was done using the pwr27 package in R.28 Let n1 and n2 be the number
of cases and controls, p1 and p2 the allele frequency for cases and controls
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h and feasible values for p1 and p2, the difference in allele frequency
between cases and controls can be calculated. Cohen29 suggests that
h values of 0.2, 0.5 and 0.8 represent small, medium and large effect sizes,
respectively.
Our analysis suggested that 200 cases and 200 controls would be
sufﬁcient to detect 80% true positives and a medium size effect (deﬁned
by the Cohen’s h parameter; Supplementary Figure S1) when m= 100 000
variants are tested for association (a value that overcomes the ﬁnal number
of variants used in the association analysis). On the basis of the effect sizes
for the m= 19 variants associated with MDD in the Mexican-American
sample (Table 1A), the post-hoc power ranges between460% (exm2249659,
h= 0.335) and499% (exm1508600, h= 0.643). Overall, these ﬁgures indicate
that our study had power to detect medium to large effect sizes regardless
of the strategy used (that is, GWAS or sequential-based).
Genotyping and analyses
Whole-exome genotyping. Both cohorts were genotyped by the Australian
Genome Research Facility (www.agrf.org.au) using the Illumina HumanEx-
ome BeadChip-12v1_A, which exonic content consists of 4250 000
markers representing diverse populations and a range of common
conditions. Samples with calls below the Illumina (Illumina Australia and
New Zealand, Scoresby, VIC, Australia) expected 99% SNP call rates were
excluded. An individual was duplicated to test genotyping reliability and
quality. The identity by descent (IBD) matrix between all pairs of individuals
was estimated after linkage disequilibrium (LD) pruning and used for
quality control and for the mixed linear models analyses.
Quality control and ﬁltering for functional and rare variants. GenomeStu-
dio data were analyzed by SNP & Variation Suite (SVS) 7.6.7, Golden Helix’s
(Golden Helix, Bozeman, MT, USA (http://www.goldenhelix.com). Para-
meters for excluding markers from analyses included: (i) deviations from
Hardy–Weinberg equilibrium with P-values o0.05/m (where m is the
number of markers included for analysis); (ii) a minimum genotype call rate
of 90%; (iii) the presence of more than two alleles; and (iv) monoallelism.
The minor allele frequency (MAF) of 0.01 was the criterion for deﬁning
common (⩾0.01) and rare variants (o0.01).
Functional variants ﬁltering and classiﬁcation. We ﬁltered against func-
tional prediction information available in the dbNSFP_NS_Functional_Pre-
dictions annotation track GRCh_37 to deﬁne variation with potential
functional effect.30 This ﬁlter uses SIFT, PolyPhen-2, MutationTaster,
Gerp++ and PhyloP.31–33 We used the SVS 7.6.7, Golden Helix’s Variant
Classiﬁcation module to examine the interactions between variants and
gene transcripts to categorize variants based on their potential functional
effects. Non-coding variants were tested for being harbored in splicing
sequences, enhancers, CTCF (CCCTC-binding factor) binding sites, tran-
scription factor binding sites, open chromatin regions, CpG islands, DNA
and histone methylation sites, polymerase binding, and target sites of
microRNAs and RNA-binding proteins.
GWAS analysis of common and rare variants. We studied the association
of MDD to functional variations using single- and multi-locus LMEMs34 with
up to 10 steps in the backward/forward optimization algorithm. These
models include both ﬁxed (genotype markers, sex and years of education)
and random effects (family or population structure), the latter to account
for potential inbreeding by including the IBD matrix (which was estimated
between all pairs of individuals after LD pruning in our analysis).34 A single-
locus LMEM assumes that all loci have a small effect on the trait, whereas a
multi-locus LMEM assume that several loci have a large effect on the trait.34
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Both types of models were implemented in SVS 8.3.0. (Golden Helix). The
optimal model was selected using a comprehensive exploration of
multiple criteria including the Extended Bayes Information Criteria (eBIC),
the Modiﬁed Bayes Information Criteria (mBIC) and the Multiple Posterior
Probability of Association (mPPA). After the estimation process using the
forward/backward algorithm was ﬁnished, the coefﬁcients β^1; β^2; ¼ ; β^m
were extracted and a hypothesis test of the form H0,i: βi= 0 vs H1,i: βi≠0 was
performed for the ith common exonic functional variants to obtain the
corresponding P-value (i= 1,2,…,m). Thus, the collection P1, P2,…,Pm of
P-values were corrected for multiple testing using the false discovery rate
(FDR)35 and a method based on extreme-values theory.36 Because
hypotheses testing were of the same type, correction was only performed
on the resulting m P-values.35,36 For the single-locus models, we estimated
the Genomic Control ‘inﬂation factor’ λ, to evaluate potential stratiﬁcation
effects.
We used the regression- and the permutation-based kernel-based
adaptive cluster (KBAC) methods to analyse rare exonic functional
variants.18,37 KBAC, implemented in the Golden Helix’s SVS 8.3.0, catalogs
rare variant data within each of a number of regions/transcripts into multi-
marker genotypes and determines their association with the phenotype,
weighting each multi-marker genotype by how often that genotype was
expected to occur according to control and MDD cases data and the null
hypothesis that there is no association between that genotype and the
case/control status.18,37 Thus, genotypes with high sample risks are given
higher weights that potentially separate causal from non-causal geno-
types. A one-sided test was applied due to the weighting procedure and
the P-values were estimated using 10 000 permutations.
Sequential test in the Mexican-American cohort. As an instrument of cross-
validation we applied a sequential strategy of analysis by examining 50%
of the Mexican-American individuals randomly chosen, and using the
remaining set of individuals to replicate only those markers reaching
genome-wide FDR o0.05 during the ﬁrst round.
Replication study in the European-ancestry cohort. We used a replication
European-ancestry cohort; functional variations harbored in genes, or
nearby 30 kb, signiﬁcantly associated with MDD in the Mexican-American
sample were ﬁltered in and tested for GWAS analysis of common and rare
variations. For rare variants we performed KBAC with permutation testing on
CCDS (consensus coding sequence) genes 15, UCSC (rfs://data.goldenhelix.
com:80/rfs/CCDSGenes15-UCSC_2014-02-16_GRCh_37_Homo_sapiens.tsf:1).
A matrix of IBD for the LMEMs analyses was generated with common
variation ﬁltered out after the targeting of genes associated in the ﬁrst tier.
The criterion for replication was a P-value of 0.10 after correction for multiple
comparisons using FDR.
Haplotype analyses. Haplotype analyses were performed using Golden
Helix. In the Mexican-American and European-ancestry cohorts, we
interrogated the chromosomal region with the strongest replication
signals to characterize LD blocks and transmission. Lewontin’s D statistics
was applied to those analyses because it is unaffected by rare allele
frequencies.38
Whole-genome sequencing and analysis
A small subset of both cohorts (15 Mexican-American samples and 10
Australians of European-ancestry samples) was sequenced using Illumina
HiSeq 2000 (BGI, Shenzhen, Guangdong, China) or HiSeq X (Garvan
Institute, Sydney, NSW, Australia). Whole-genome sequencing paired-end
reads were aligned to the human reference genome (hg19, Genome
Reference Consortium GRCh37) using Burrows-Wheeler Aligner (BWA)39 to
get SAM (sequence alignment/map) format ﬁles. Then SAMtools40 was
used to convert the SAM to the BAM (Binary version of a SAM ﬁle) format
ﬁles. After internal sorting, BAM ﬁles were merged into one BAM ﬁle
(where one sample may include several lanes of sequencing reads). We
used the mpileup command in SAMtools to collect summary information
from the BAM ﬁle, calculate the likelihood of data given each possible
genotype, and store the likelihoods in a binary ﬁle. We then piped the
output to SAMtools/BCFtools,41 which makes the SNV (single nucleotide
variant)/INDEL (small insertions and deletions) calling to generate the VCF
(variant call format) ﬁles. After that, we used ANNOVAR42 to annotate the
SNP/INDEL information and their classiﬁcation details in those VCF ﬁles.
Pathway and network analyses
We evaluated potential common ontogenetic and cellular function
processes of the genes disclosed by the GWAS analysis on rare and
common variants using Metacore 6.8 software build 29806 (GeneGo, St.
Joseph, MI, USA).
Brain eQTL analyses
We used the UK Brain Expression Consortium (UKBEC) web based server
Braineac (Brain eQTL Almanac, http://www.braineac.org/) to understand
whether some genetic polymorphisms have signiﬁcant statistical associa-
tion with transcription level (expression quantitative trait loci, eQTL) in ten
brain regions (cerebellum, frontal cortex, hippocampus, medulla, occipital
cortex, putamen, substantia nigra, thalamus, temporal cortex and central
white matter).43
Table 1A. Genome-wide variants signiﬁcantly associated with major depressive disorder
SNP Chr rs ID Gene Major
allele




HGVS coding 1 HGVS protein
exm167893 1 rs41310573 OR2T12 T 4.39E− 20 3.59E− 15 0.30 0.07 c.115A4G p.Ser39Gly
exm1508600 19 rs201935337 TMEM150B C 4.77E− 11 1.95E− 6 0.10 0.00 c.136G4A p.Gly46Arg
exm1616604 22 rs140395831 PRR5-
ARHGAP8
A 3.01E− 10 6.16E− 6 0.09 0.00 c.1252A4C p.Ser418Arg
exm875366 11 rs56293203 MUC5B G 1.57E− 9 2.57E− 5 0.13 0.02 c.442G4A p.Val148Ile
exm283068 2 rs78562453 C2orf54 C 6.23E− 8 7.28E− 4 0.06 0.00 c.36G4C p.Arg12Ser
exm445797 5 rs115054458 TRIO C 3.43E− 7 3.51E− 3 0.08 0.01 c.7391C4T p.Ala2464Val
exm1441979 19 rs143696449 ANO8 G 4.55E− 7 4.13E− 3 0.06 0.00 c.3206C4T p.Ala1069Val
exm669085 7 rs748441912 KRBA1 A 4.94E− 7 4.04E− 3 0.11 0.02 c.2535G4A Synonymous
exm75804 1 rs62001028 BCAR3 G 5.32E− 7 3.96E− 3 0.07 0.00 c.820C4T p.Arg274Trp
exm1355772 17 rs150952348 UNC13D T 6.71E− 7 4.57E− 3 0.06 0.00 c.3160A4G p.Ile1054Val
exm1044842 12 Rs782472239 ORAI1 C 9.12E− 7 5.74E− 3 0.08 0.00 c.638C4A p.Pro213His
exm1435859 19 rs112610420 EMR2 T 1.22E− 6 7.15E− 3 0.07 0.00 c.875A4C p.Tyr292Ser
exm1325307 17 rs142029931 CNTNAP1 G 1.31E− 6 7.16E− 3 0.06 0.00 c.2501G4A p.Arg834His
exm1505393 19 rs201483250 LILRA1 C 1.48E− 6 7.55E− 3 0.17 0.06 c.535C4T p.Arg179Trp
exm1369092 17 rs200897153 FASN C 2.49E− 6 0.01 0.10 0.01 c.5801G4A p.Arg1934His
exm1293569 17 rs3744550 MYH13 T 3.57E− 6 0.02 0.30 0.15 c.5585A4G p.His1862Arg
exm782507 9 rs115668237 SLC2A8 C 5.87E− 6 0.03 0.04 0.00 c.1239C4G p.Cys413Trp
exm2249659 11 rs56344012 MUC5B A 1.04E− 5 0.04 0.07 0.01 c.15861A4G Synonymous
exm2275308 19 rs200520741 HOMER3 C 1.05E− 5 0.04 0.05 0.00 Splicing Splicing
Abbreviations: Chr, chromosome; FDR, false discovery rate; Freq., frequency; HGVS, Human Genome Variation Society; rs ID, reference SNP identiﬁcation
number; SNP, single nucleotide polymorphism.
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Animals
Procedures were approved by the Animal Ethics Committees of the South
Australian Health and Medical Research and Flinders University and are in
accordance with the Australian Code for the Care and Use of Animals
for Scientiﬁc Purposes (8th edition, 2013). Virus- and antibody-free young
adult male Sprague–Dawley rats (150–200g) obtained from Charles River
(Margate, Kent, UK) were individually housed in Green Line IVC Sealsafe
PLUS cages (Tecniplast, Varese, Italy) in a temperature- (22 ± 1 °C) and light-
(12 h cycles, lights on at 07:00 hours) controlled, stress-free and speciﬁc
pathogen-free environment with water and standard regular chow ad
libitum. They were allowed to habituate at least 5 days before the initiation
of experimental procedures. After the baseline behavioral testing, rats were
assigned to one of two groups so that the range of ﬂoating time was
similarly distributed and there was no ﬂoating time differences between
groups before treatment: (i) chronic restraint stress (CRS, n= 27) and (ii)
non-CRS (n= 10) groups. Moreover, the CRS group was further classiﬁed
into CRS resilient and CRS non-resilient subgroups (see ‘Statistical analyses’
section below). The investigator was not blinded to group allocation;
however, most of the behavioral data were collected by a camera coupled
to a software (EthoVision, Noldus Information Technology, Wageningen,
The Netherlands). The number of animals was decided based on pilot
studies carried out in the lab.
Chronic restraint stress. Flat-bottom clear acrylic restraint containers
(20.3 × 8.3 cm; cat no. 544-RR Plas Labs, Lansing, MI, USA) were used as
previously described.44 For 14 consecutive days during daytime (09:00–
16:00 hours) CRS rats were submitted to six consecutive hours of restraint,
after which they were unrestrained and returned to their home cages.
Non-CRS animals were submitted to behavioral testing but not restrained.
Forced swim test. We used the automatic video-tracking EthoVision XT
video tracking software (EthoVision) to record and analyze the behavior
and activity of our animals during the forced swim test (FST). Tests were
performed between 09:00 and 12:00 hours after a 60 min habituation to
the testing room. At baseline and after the CRS paradigm, the pre-test
(training) was carried out for 10 min and was followed 24 h later by the
test. Rats were individually tested in a glass cylinder (45 cm height and
30 cm diameter), which contained 30 cm of water (the rat’s hindlimbs did
not reach the cylinder’s ﬂoor) at 23 °C for 5min. Activity was recorded by
one perpendicular camera located in the front; automated measurements
of ﬂoating/immobility (o12% of distance moved) and struggling/highly
mobile activity (418.5% of distance moved) were obtained twice
per second using the EthoVision XT software.45 After the test, rats were
dried and placed in a 30 °C drying environment for ~ 10–15 min. FST was
performed at baseline and four weeks later, at which time the CRS
paradigm had been completed.
RNA extraction. After the last behavioral testing, animals were allowed to
rest at least 2 days before being killed. To avoid the confounding effects of
circadian rhythms, animals were killed between 10:00 and 12:00 hours.
Brains were remove from the skull, immediately submerged in RNAlater
solution and stored overnight at 4 °C; supernatant was then removed and
brains were dissected and stored at − 80 °C until use. Total RNA was
isolated from hippocampi using the Purelink RNA Mini Kit (Life
Technologies, Mulgrave, VIC, Australia), and DNase digestion was
performed using the Purelink DNase set (Life Technologies). RNA was
quantiﬁed using a spectrophotometer (NanoDrop 2000, Thermo-Fisher
Scientiﬁc, Waltham, MA, USA) and 500 ng total RNA was reversed
transcribed to cDNA using iScript RT supermix (BioRad, Hercules, CA, USA)
and random hexamer primers.
Quantitative real-time reverse transcriptase. Primers for each gene of
interest were exon spanning, designed using the IDT primer quest tool
(Integrated DNA Technologies, Baulkham Hills, NSW, Australia)
or the primer premier 5 software (Premier Biosoft International, Palo Alto,
CA, USA). Amplicon lengths were between 76 and 135 bp. We employed
the Bestkeeper46 and the geNorm47 softwares to select 2 out of 5 reference
genes we tested. The following primer pairs were used:Phf21bF: 5′-CAGCG
GAAGGCCTTAAAGAA-3′; Phf21bR: 5′-CACTGTCTTGTGGGTGACATAG-3′;
Rps18F: 5′-TTCAGCACATCCTGCGAGTA-3′; Rps18R: 5′-TTGGTGAGGTCAAT
GTCTGC-3′; GapdhF: 5′-CCATTCTTCCACCTTTGATGCT-3′; GapdhR: 5′-TGTC
ATACCAGGAAATGAGCTTCA-3′.
A standard curve of pooled, serially diluted cDNA was run for the Phf21b
gene and for housekeeping genes (Gapdh and Rps18) using the
QuantStudio 7 Flex Real-Time PCR system (Thermo-Fisher Scientiﬁc). cDNA
samples were diluted 1:4 and run in triplicates. Primer sets were tested for
optimal dissociation curves with ampliﬁcation efﬁciencies between 94 and
107%. To check for genomic contamination, a minus-reverse transcriptase
control of each sample was run in an quantitative real-time reverse
transcriptase (RT-qPCR) experiment. The geometric mean of both house-
keeping genes was used to calculate the results. Only reactions with
threshold cycle (CT) standard deviation values ⩽ 0.3 were accepted.
Statistical analyses
Mirroring our clinical approach, our analyses took into consideration the
stress level displayed by animals under non-chronically stressed condi-
tions, as our rats were individually housed and social isolation can increase
anxiety- and depressive-like behaviors.48–50 In both groups, we excluded
non-chronically stressed animals that displayed increased ﬂoating time at
baseline (in the CRS group) or increased averaged ﬂoating time (in the
non-CRS group), which was deﬁned as ﬂoating time higher than the post-
CRS FST ﬂoating time mean. We classiﬁed the CRS group into CRS resilient
(below average baseline and post-CRS ﬂoating times) and CRS non-
resilient. Differences between groups were analyzed by the Student-paired
t-test or one-way ANOVA when appropriate. The signiﬁcance level for each
of these effects was set at Po0.05. We used the Pfafﬂ method to calculate
RT-qPCR data.51 Statistical analyses were performed using GraphPad Prism
6 (GraphPad Software, La Jolla, CA, USA).
RESULTS
Genotyping analyses
GWAS analysis of common and rare variants in the Mexican-
American cohort. We obtained Illumina HumanExome BeadChip-
12v1_A genotype data from 399 Mexican-American subjects
(203 MDD cases and 196 controls) and 972 European-ancestry
subjects (499 MDD cases and 473 controls). After ﬁltering out
markers not meeting either quality control criteria or variability
requirements 83 898 variants remained for analyses (Figure 1). In
the Mexican-American cohort, a total of 19 common SNPs in 18
genes were signiﬁcantly associated with MDD at the genome-
wide FDR o0.05 (Figure 2; Table 1A); two SNPs were found in the
MUC5B gene. Sixteen nonsynonymous SNPs out of the nineteen
genome-wide associated SNPs predicted functional protein effects
and eleven MDD-associated SNPs were rare variants in controls
(MAFo0.01). Haplotype analysis reported the clustering of
markers with signiﬁcant association to four conspicuous regions
harboring the OR2T12 (Chr 1), TMRM150B (Chr 19), SLX4 (Chr 16)
and TRPM2 (Chr 21) genes (Supplementary Figures S2A–D).
We next applied the KBAC method to 47 296 rare exonic
variants with potential functional effects. Twenty-seven genes
were signiﬁcantly associated with MDD in the Mexican-American
cohort (Table 1B). Functional SNPs harbored in ﬁve of these genes,
ANO8, CNTNAP1, EMR2, HOMER3, UNC13D, were signiﬁcantly
associated with MDD in common and rare variants analyses
(Tables 1A and 1B).
Sequential test in the Mexican-American cohort. For cross-valida-
tion, we performed a sequential strategy by ﬁrst analyzing data of
50% randomly chosen Mexican-American individuals, and then
using the remainder 50% to replicate only those markers reaching
genome-wide FDR o0.05 during the ﬁrst round. Ten of the
thirteen SNPs signiﬁcantly associated with MDD in the sequential
analyses (Table 1C) also achieved signiﬁcance (FDRo0.05) in the
GWAS analysis (Table 1A).
Replication study in the European-ancestry cohort. Functional
variations harbored in or 30 kb around genes signiﬁcantly
associated with MDD in the Mexican-American sample were
next tested by GWAS analysis of common and rare variations in
the European-ancestry cohort. The rare variant analysis using
the KBAC method identiﬁed the PHF21B gene (Table 2), which is
adjacent to the PRR5-ARHGAP8 gene within the chromosome
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N=203 MDD & 196 controls 
European-ancestry  
N=400 MDD & 400 controls  
247,909 Variants 
83,898 Variants 
Call rate < 0.90 
Number of alleles  2 
H-W Equilibrium 
deviations in both cases 
and controls p<2x10-7
Functional Filtering using  
SIFT, PolyPhen2, 
MutationTaster, Gerp++, 
phyloP to exclude 
tolerated and conserved 
variants. 
Non-exonic 
Variants in controls with 
major allelic frequency > 
0.01 
47,296 Variants 
Criterion for filtering out.  
Remaining Variants 
Available for Analyses 
Figure 1. Flow diagram describing the process of ﬁltering out low quality and functionally irrelevant variants. From 247 909 variants, 164 011
variants were discarded because they were monoallelic, had more than two alleles, had a call rate of o90%, or because their genotype
proportions deviated from the expected ones as deﬁned by the Hardy-–Weinberg (H–W) equilibrium law in both cases (patients with major
depression) and controls at a P-value of 2 × 10− 7. The remaining 83 898 variants were used for exome-wide association analysis. After
additional functional ﬁltering using several tools (SIFT, PolyPhen-2, MutationTaster, Gerp++ and phyloP) to exclude tolerated and conserved
variants, and after the exclusion of non-exonic variants and variants in the control subjects with allelic frequency40.01, the remaining 47 296
variants were used in rare variant analysis. MDD, major depressive disorder.
Figure 2. Manhattan plots for a GWAS of major depressive disorder (MDD) in a cohort of Mexican-American patients (n= 203) and matched
controls (n= 196). Results of the GWAS using an additive model after correcting stratiﬁcation by principal component analysis. In the inset, the
ﬁrst and second principal components that shows absence of genetic stratiﬁcation (left box), and the Q–Q plot of observed vs expected of the
− log10 (P-values, right box). The estimated Genomic Control ‘inﬂation factor’ λ was 1. GWAS, genome-wide association study.
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22q.13 region identiﬁed in Mexican-Americans. It is noteworthy to
mention that the frequencies of genetic variants were different
between both cohorts (see ‘WGS analyses’ section below).
Haplotype analyses of Chr 22q13.1. Haplotype analyses were
performed in Chr 22q13.1 in both cohorts encompassing
the region showing the highest replication signals in Table 2,
namely the PRR5, ARHGAP8 and PHF21B genes (Supplementary
Figure S3). The LD structure of this chromosomal region appears
to be more conserved in the European-ancestry cohort than
in the Mexican-American cohort. It is evident that this
chromosomal region is transmitted as a heterogeneous block.
Therefore, diversity of the results in our two cohorts might
be explained by the complex evolutionary heterogeneity of this
region.
WGS analyses
We performed WGS to better understand variations within and
between each of the two cohorts we studied. WGS analyses
showed that Mexican-American individuals had signiﬁcantly more
SNVs (50% more) and less INDELs (small insertions and deletions)
Table 1B. Rare variants analysis using the KBAC method after ﬁltering out: tolerated and non-conserved, non-exonic and variants that in controls
had a MAF 40.01








# Markers # Multi-marker
genotypes
19 17 434 032 17 445 638 ANO8 9.99E− 04 0.08 0.03 399 2 4
19 11 485 383 11 487 627 C19orf39 9.99E− 04 0.06 0.03 399 2 4
19 3 136 191 3 163 766 GNA15 9.99E− 04 0.07 0.04 399 3 4
15 78 287 327 78 369 994 TBC1D2B 9.99E− 04 0.07 0.04 399 3 5
12 6 419 602 6 437 672 PLEKHG6 9.99E− 04 0.07 0.05 399 5 6
19 19 040 010 19 052 041 HOMER3 2.00E− 03 0.06 0.04 399 3 4
19 14 843 205 14 889 353 EMR2 2.00E− 03 0.10 0.04 399 10 13
17 73 823 308 73 840 798 UNC13D 2.00E− 03 0.09 0.04 399 8 14
12 55 945 011 55 945 940 OR6C4 2.00E− 03 0.07 0.04 399 6 7
11 67 776 048 67 796 743 ALDH3B1 2.00E− 03 0.07 0.05 399 4 5
10 135 051 408 135 055 433 VENTX 3.00E− 03 0.06 0.04 399 2 4
9 139 607 024 139 619 170 FAM69B 3.00E− 03 0.08 0.04 399 1 3
8 145 747 761 145 752 416 LRRC24 3.00E− 03 0.07 0.05 399 3 5
7 16 639 401 16 685 442 ANKMY2 3.00E− 03 0.09 0.05 399 3 4
4 2 965 343 3 042 474 GRK4 3.00E− 03 0.14 0.05 399 7 10
17 40 950 854 40 963 605 CNTD1 4.00E− 03 0.07 0.04 399 4 5
17 40 834 632 40 852 011 CNTNAP1 4.00E− 03 0.07 0.04 399 4 5
16 1 664 641 1 727 909 CRAMP1L 4.00E− 03 0.07 0.04 399 6 7
12 110 220 892 110 271 212 TRPV4 4.00E− 03 0.05 0.04 399 4 6
11 4 615 269 4 616 243 OR52I1 4.00E− 03 0.06 0.05 399 1 2
11 1 012 824 1 036 706 MUC6 4.00E− 03 0.11 0.05 399 14 18
9 125 486 269 125 487 204 OR1L4 4.00E− 03 0.08 0.05 399 3 5
17 48 638 449 48 704 542 CACNA1G 5.00E− 03 0.07 0.04 399 5 7
14 44 973 354 44 976 499 FSCB 5.00E− 03 0.05 0.05 399 5 6
11 66 059 373 66 064 135 TMEM151A 5.00E− 03 0.05 0.05 399 1 2
10 72 530 995 72 545 157 C10orf27 5.00E− 03 0.07 0.05 399 2 4
9 130 928 344 130 966 662 CIZ1 5.00E− 03 0.07 0.05 399 6 8
Abbreviations: Chr, chromosome; FDR, false discovery rate; KBAC, kernel-based adaptive cluster; MAF, minor allele frequency.
Table 1C. Genome-wide variants signiﬁcantly associated with major depressive disorder after using a sequential strategy
SNP Chr rs ID Gene Major
allele




HGVS coding 1 HGVS protein
exm167893 1 rs41310573 OR2T12 T 8.06E− 10 1.74E− 06 0.30 0.06 c.115A4G p.Ser39Gly
exm1472172 19 rs201138159 RABAC1 9.87E− 08 1.07E− 04 0.17 0.00 c.107A4G p.Glu36Gly
exm875366 11 rs56293203 MUC5B G 7.48E− 07 5.38E− 04 0.15 0.00 c.442G4A p.Val148Ile
exm1508600 19 rs201935337 TMEM150B C 2.39E− 06 1.29E− 03 0.13 0.00 c.136G4A p.Gly46Arg
exm1616604 22 rs140395831 PRR5-ARHGAP8 A 1.15E− 05 4.97E− 03 0.10 0.00 c.1252A4C p.Ser418Arg
exm445797 5 rs115054458 TRIO C 4.73E− 05 1.70E− 02 0.11 0.01 c.7391C4T p.Ala2464Val
exm75804 1 rs62001028 BCAR3 G 5.70E− 05 1.76E− 02 0.11 0.00 c.820C4T p.Arg274Trp
exm1577187 21 rs142151549 TRPM2 T 8.95E− 05 2.42E− 02 0.12 0.00 c.4364T4G p.Val1455Gly
exm646600 7 rs112002983 LRWD1 A 9.60E− 05 2.30E− 02 0.11 0.00 c.794A4C p.Asp265Ala
exm1435859 19 rs112610420 EMR2 T 1.08E− 04 2.33E− 02 0.10 0.00 c.875A4C p.Tyr292Ser
exm1355772 17 rs150952348 UNC13D T 1.15E− 04 2.25E− 02 0.08 0.00 c.3160A4G p.Ile1054Val
exm1505393 19 rs201483250 LILRA1 C 2.19E− 04 3.93E− 02 0.20 0.05 c.535C4T p.Arg179Trp
exm669085 7 rs748441912 KRBA1 A 2.53E− 04 4.19E− 02 0.13 0.01 c.2535G4A Synonymous
Abbreviations: Chr, chromosome; FDR, false discovery rate; Freq., frequency; HGVS, Human Genome Variation Society; rs ID, reference SNP identiﬁcation
number; SNP, single nucleotide polymorphism. Fifty percent of the sample was randomly selected for discovery and the remaining 50% for join analyses.
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when compared with Australian individuals of European-ancestry
(Table 3; Supplementary Table S3). Our data are compatible with
ﬁndings from the International HapMap 3 Consortium and the
1000 Genomes Project Consortium, as they respectively showed
that individuals with African ancestry carry an increased number
of variants and rare variants, and within Europeans the Spanish
population carry excess of rare variants.52,53 As the HapMap
Mexican-American samples from Los Angeles and our Mexican-
American cohort were recruited from the same location by our
bilingual research team, their median ancestry proportions are
estimated to be 45% Indigenous American, 49% European and 5%
African.54
Pathway and network analyses
MDD-associated genes in the Mexican-American cohort were
overrepresented in the following Gene Ontology (GO) processes:
(1) natural immune response (granuloma formation, natural killer
cell degranulation, synaptic vesicle priming, natural killer cell
activation, germinal center formation), (2) G-protein-coupled
glutamate receptor signaling pathway, (3) detection of chemical
stimulus involved in smell sensory perception, (4) cellular response
to stimulus, (5) regulation of macromolecule metabolic processes,
(6) muscle contraction, (7) cell surface receptor process (G-protein
coupled receptor signaling pathway, system process, neurological
system process), (8) regulation of ion transmembrane transport
Table 4. Hippocampal quantitative gene expression analyses for PHF21B gene variants extracted from the Braineac web server (UK Brain Expression
Consortium, UKBEC)
rs ID Variant Expr ID P-value Tissue Genotype_counts Allele_frequency
rs1003851 chr22:44782265 3963529 3.90E− 05 HIPP CC= 5; CT= 46; TT= 76 C= 20.9%; T= 79.1%
rs117160508 chr22:45442461 3963529 1.60E− 04 HIPP CC= 1; CG= 12; GG= 119 C= 5.2%; G= 94.8%
rs118154683 chr22:45442465 3963529 1.60E− 04 HIPP TT= 1; TA= 12; AA= 119 T= 5.2%; A= 94.8%
rs75806917 chr22:45442547 3963529 1.60E− 04 HIPP GG= 1; GT= 11; TT= 119 G= 4.9%; T= 95.1%
rs8138025 chr22:45974757 3963548 1.90E− 04 HIPP AA= 19; AG= 63; GG= 52 A= 37.7%; G= 62.3%
rs5765490 chr22:45974913 3963548 2.10E− 04 HIPP TT= 19; TC= 63; CC= 52 T= 37.7%; C= 62.3%
rs62228464 chr22:45113754 3963550 6.60E− 05 HIPP CC= 18; CA= 51; AA= 61 C= 32.5%; A= 67.5%
Abbreviations: chr, chromosome; Expr ID, expression identiﬁcation; HIPP, hippocampus; rs ID, reference single nucleotide polymorphism identiﬁcation number.
Table 3. Whole-genome sequencing analysis of 25 human samples
Sample Total SNVs Total INDELS Total variations dbSNP dbSNP% Exonic Synonyms Non-synonyms Intronic
AU mean (n= 10) 390 1078 546 756.6 4 447 834.6 3 900 468.9 87.7 23 942.4 12 613.4 11 329 1 318 630
AU SD (n= 10) 37083.5 35237.0 67382.1 51576.2 0.4 291.1 142.3 177.9 8851.6
MA mean (n= 15) 772 9021.3 517 554.1 8 246 575.4 3 995 923.3 48.6 114 430.9 31 641.7 82 789.1 2 927 921
MA SD (n= 15) 413 339 5041.5 412 190.9 43 721.7 2.7 7998.5 1800.7 6263 179 407.6
T-test, P 2.09E− 15 0.028 7.05E− 16 0.00016 7.22E− 19 1.99E− 16 3.64E− 16 1.83E− 16 4.70E− 15
Mann–Whitney U, P 3.59E− 05 9.65E− 04 3.59E− 05 5.27E− 04 3.59E− 05 3.59E− 05 3.59E− 05 3.59E− 05 3.59E− 05
Sample Intergenic Splicing 3′ UTR3 5′ UTR Down-stream Up-stream ncRNA exonic ncRNA intronic ncRNA splicing
AU mean (n= 10) 2 246 762 111.5 25 759.4 5859.9 25 626.1 25 116 12 966.1 217 112.9 71.4
AU SD (n= 10) 25 571.3 8.6 176.9 68.6 360.3 324.1 150.1 3070.5 5.3
MA mean (n= 15) 4 015 894 5630.7 66 925.8 28 831.7 63 537.3 82 268.7 29 111.9 397 645.2 338.1
MA SD (n= 15) 198 644.7 287.1 4324.0 5222.3 4372.6 5407.0 1497.9 19 516.4 22.1
T-test, P 2.16E− 15 1.24E− 19 2.15E− 15 9.28E− 11 5.76E− 15 4.37E− 16 2.11E− 16 7.52E− 16 1.61E− 18
Mann–Whitney U, P 3.59E− 05 3.58E− 05 3.59E− 05 3.59E− 05 3.59E− 05 3.59E− 05 3.59E− 05 3.59E− 05 3.53E− 05
Abbreviations: AU, Australian; dbSNP, the single nucleotide polymorphism database; INDELS, small insertions and deletions; MA, Mexican-American; ncRNA,
non-coding RNAs; SD, standard deviation; SNVs, single nucleotide variants; 3′ UTR, three prime untranslated region; 5′ UTR, ﬁve prime untranslated region.
Table 2. Rare variants analysis using the KBAC method in the European-ancestry cohort: tolerated and non-conserved, non-exonic and variants that
in controls had a MAF 40.01










# Markers # Multi-marker
genotypes
22 45248966 45435430 PHF21B CCDS46727.1 0.001 0.027 0.068 972 6 6
22 45152408 45288475 ARHGAP8 CCDS33664.1 0.003 0.027 0.102 972 16 8
22 45248966 45434692 PHF21B CCDS56234.1 0.001 0.027 0.102 972 6 6
22 45248966 45435430 PHF21B CCDS14061.1 0.002 0.027 0.102 972 6 6
22 45152408 45288475 ARHGAP8 CCDS14060.2 0.003 0.027 0.123 972 16 8
Abbreviations: Chr, chromosome; FDR, false discovery rate; KBAC, kernel-based adaptive cluster; MAF, minor allele frequency.
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(regulation of calcium ion transport and activity) and (9) positive
regulation of cellular metabolic process (Supplementary Table S4).
Brain eQTL analyses
Data extracted from the Braineac web server (UK Brain Expression
Consortium, UKBEC) revealed that PHF21B gene variants signiﬁ-
cantly change eQTL in all ten listed brain areas (Supplementary
Table S5). Seven listed variants change hippocampus eQTL
(Table 4).
Animal study
Our genetic analyses were performed on two cohorts that,
uniquely, took into consideration levels of stress data in control
groups to minimize the impact of individuals genetically at-risk for
MDD in the control population and thereby maximize the
likelihood of identifying novel MDD-associated variants. This
approach revealed that rare functional variants in the PHF21B
gene are associated with MDD in both cohorts and brain eQTL
showed PHF21B gene variants could signiﬁcantly change expres-
sion in several brain areas. To further analyze the association
between PHF21B, depression and stress, we exposed male
Sprague–Dawley rats to CRS (see ‘Materials and methods’ section),
and analyzed the effect on ﬂoating/immobility time in the FST,
which is a measure of behavior despair and depressive-like
behavior. CRS resulted in small but signiﬁcantly increased
ﬂoating time in the FST in CRS non-resilient animals but not in
the CRS resilient ones (Figure 3a; Supplementary Table S6).
Importantly, Phf21b mRNA levels were signiﬁcantly decreased in
the CRS-resilient group when compared with the non-CRS group,
but not in the CRS non-resilient group (Figure 3b). Therefore,
Phf21b gene expression level may reﬂect a state of resilience to
chronic stress.
DISCUSSION
We presented results that support the assumption that MDD is a
syndrome of considerable genetic heterogeneity, as we identiﬁed
many common and rare functional variants that confer suscept-
ibility to MDD in the Mexican-American cohort. Those variations
withstood the use of stringent correction measures related to
genetic stratiﬁcation and repeated testing. Interestingly, 11 out of
19 SNPs with signiﬁcant genome-wide association to MDD con-
sisted of rare variants in the control population; the data strongly
support a Mendelian type of inheritance for many of the rare
variants. Remarkably, ﬁve genes were identiﬁed in both common
and rare variant analyses, and one gene had two SNPs that were
signiﬁcantly associated with MDD in our GWAS analysis.
Our replication strategy in the European-ancestry cohort
included testing functional variations harbored in genes, and
extended to include nearby 30 kb, signiﬁcantly associated with
MDD, in GWAS analysis of common and rare variations, in the
Mexican-American. This strategy replicated the PHF21B (PHD
ﬁnger protein 21B, also known as BHC80L or PHF4) gene, which
encodes the 531 amino acid PHD ﬁnger protein 21B. The PHF21B
gene and the neighboring ARHGAP8 (Rho GTPase activating
protein 8) gene provided the strongest signals in our replication
analysis; however, the ARHGAP8 gene did reach the signiﬁcance
threshold (Table 2). Furthermore, as the ARHGAP8 and PRR5
(Proline rich 5) genes were initially thought to be one gene
because of readthrough transcripts,55 this chromosomal locus
requires further scrutiny.
The PHF21B gene may be a putative tumor suppressor gene
whose loss of function results from reduced expression by
hypermethylation or gene loss.56 This gene is expressed in the
brain and its variants affect its expression in several brain regions,
including the frontal cortex and the hippocampus (Brain eQTL
Almanac, http://www.braineac.org/); though, its central nervous
system functions are unknown. However, its prominent paralog,
the PHF21A gene, encodes BHC80 (a component of a BRAF35/
histone deacetylase complex), which is a transcriptional repressor
during neurodevelopment highly expressed in the brain.57–59
Both the PHF21A and the PHF21B genes have the PHD zinc
ﬁnger domain, the DNA-binding domain and the region required
for transcriptional repression, and localize in the nucleus.56
The PHF21B gene is located in Chr 22q13.31, which is a genomic
region associated with the Phelan-McDermid syndrome
(or 22q13.3 deletion syndrome/22q13.3DS), a rare neuro-
developmental disorder that typically presents with generalized
developmental delay, intellectual disability, delayed speech and
seizures, and involves the SHANK3 gene.60 The SHANK3 gene
encodes a protein that has a role in synapse formation and
dendritic spine maturation, and mutations in this gene cause
autism spectrum disorder and schizophrenia.61,62 It is noteworthy
that the nearby 22q11.2 deletion syndrome [22qDS/velocardiofacial
syndrome (VCFS)/DiGeorgio syndrome/CATCH22] is one of
the most common multiple anomaly syndromes in humans
and it also includes among its manifestations higher rates of
psychiatric disorders, including mood and schizophrenia.63,64
A large percentage (79%) of 22qDS children and adolescents














































































Figure 3. Animal studies. (a) Paired t-test showed signiﬁcantly increased ﬂoating time between the ﬁrst (T1, baseline) and the second (T2,
post-CRS) forced swim tests (FST) in the chronic restraint stress (CRS) non-resilient (nonresil, n= 8) group but not in the CRS resilient (resil,
n= 11) and the non-CRS (n= 6) groups. (b) One-way ANOVA showed that hippocampal Phf21b gene expression was signiﬁcantly decreased in
the CRS resil (resilient) group (n= 11) but not in the CRS nonresil (non-resilient) group (n= 8) comparing with the non-CRS group (n= 6);
columns=mean, bars= standard deviation of the mean. (s), seconds; AU, arbitrary units; **Po0.01; ***Po0.001.
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Results of our haplotype and sequential analyses support that
the TRPM2 gene was signiﬁcantly associated with MDD; thus,
these data may be considered as providing a replication for the
association of MDD and the TRPM2 gene, which was previously
associated by positional candidate approach with susceptibility to
bipolar disorder and unipolar disorder.68 The transient receptor
potential cation channel, subfamily M, member 2, TRPM2, is a
member of the melastatin-related transient receptor channel family
that is involved in oxidative stress-induced cell death and inﬂamma-
tion processes and has a role in endotoxin-provoked cytokine
production; TRPM2-mediated calcium inﬂux inﬂuences the reactive
oxygen species-induced signaling cascade responsible for chemokine
production and exacerbates inﬂammation via the NLRP3 (NLR family,
pyrin domain containing 3) inﬂammasome.69
Pathway analysis offered insight into the complexity of
mood regulation and MDD stereotypical behaviors and symptoms.
Many of the uncovered enriched processes are novel or under-
explored, such as cellular response to stimulus, muscle system
process, regulation of metabolic process, sensory perception of
chemical stimulus, regulation of ion transmembrane transport and
protein–DNA complex disassembly, and others have been active
areas of investigation as complementary/alternative hypothesis
for the classical monoamine hypothesis of depression, such as
neuroimmune mediation/inﬂammation and glutamate receptor
signaling pathway and growth/positive regulation of macromole-
cule biosynthetic process.70–75 The olfactory system and its central
connections may have a role in affective behavior, and bilateral
olfactory bulbectomy has been used as a rodent model for
depression since the early 1980’s.76,77 Our data may help narrow
the focus of future investigations toward speciﬁc aspects of these
broad investigative areas.
Our animal study provided evidence that hippocampal Phf21b
gene expression modulates the response to chronic stress as CRS-
resilient animals had decreased hippocampal Phf21b mRNA levels.
However, the lack of non-stressed group housed animals may
have restricted our ability to understand the baseline level of this
gene in non-socially isolated animals. GO enrichment analysis
indicated that MDD-associated genes are involved in regulation of
metabolic processes; therefore, food and water restriction during
the CRS paradigm could have impacted post-stress gene
expression levels. To minimize the effects of food and water
restriction in our experiments, CRS was performed during the light
phase when rodents do not usually consume a signiﬁcant amount
of food or water, as they are nocturnal animals.
MDD is clearly a gene-environment disorder,3 but most genetic
studies have not accounted for stressful life events in the control
population. These critical environmental factors have been used in
the present work to help minimize the inclusion of genetically
susceptible individuals in the control sample. Our Mexican-
American cohort is comprised of ﬁrst-generation individuals
(60%)23 who have experienced signiﬁcant levels of stress and
hyperactivation of the hypothalamic–pituitary–adrenal axis related
to acculturation issues.24,25 In contrast to the Mexican-American
controls represented a group of individuals who were highly
resilient to signiﬁcant levels of enduring stress, in our replication
cohort the stress levels in controls were also included in our
analyses. Furthermore, as most of the variations reported here in
the Mexican-American cohort were rare, each gene contained low-
frequency mutations at many different sites, which could help
explain the challenges experienced in this ﬁeld, as the power of
genome-wide association studies in MDD have been greatly
reduced because the critical assumption that there were little
allelic heterogeneity within loci may not apply;78 this assumption
may have been harder to negate in populations of European-
ancestry due to their drastically reduced number of SNVs (Table 3;
Supplementary Table S3). Our ﬁndings suggest that the ‘missing
heritability’ in MDD could be at least partly explained by rare
variants.
In summary, we identiﬁed common and rare variations in a total
of 44 genes that may confer susceptibility to MDD in a Mexican-
American cohort. Most of these variations were rare and resulted
in amino acid (that is, likely functional) changes. Replication of the
PHF21B gene in an ethnic diverse population and the ﬁnding that
Phf21b gene expression modulates the chronic stress response in
rats corroborate the strength of our ﬁndings. Our ﬁndings also
provide a set of common and rare genetic variants associated with
MDD that require replication. Our clinical cohorts were small;
therefore, further replication studies are warranted with larger
cohorts recruited under a similar study design to replicate and/or
identify additional genes associated with MDD. As PHF21B gene
expression could be modulated by methylation,56 future studies
should investigate whether the methylation status in this locus is
inﬂuenced by MDD diagnosis or stress, as epigenetics may
account for part of the missing heritability in complex traits.79
No previous studies have looked at Phf21b levels in stress/
depressive-like behavior; therefore, additional animal studies are
also needed to systematically characterize hippocampal Phf21b
gene expression level in non-stressed groups at baseline, and
during various types of acute and chronic stress paradigms.
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